
CLYM vs EVO
$CLYM vs $EVO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
CLYM vs EVO: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only CLYM beat the market over the past year, by 397.2%, while EVO trailed the S&P 500 at +8.8% by 60.3%.
- ·The last month has flipped the order: EVO has held up better over the month (-7.1% against -14.4%) even though CLYM leads over the year.
- ·CLYM has support 12.7% below at $8.13; EVO has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
CLYM vs EVO: the quick read
- ·CLYM is the larger company by market cap ($546M vs $519M).
- ·CLYM has been more active on our scanner (119 vs 9 alerts in 30 days).
- ·CLYM has the smaller float (57.5M vs 342.4M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·EVO trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·CLYM draws far more of our scanner's attention, 119 unusual-volume alerts in 30 days against 9, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 5% of each other on market cap, which makes the rest of this table the interesting part.
- ·EVO pays a dividend and CLYM does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching CLYM or EVO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing CLYM and EVO on TheDesperateTrader.
- Is CLYM or EVO the better stock?
- "Better" depends on your goal, and these two are not alike. CLYM is the larger company by market cap ($546M vs $519M). CLYM has been more active on our scanner (119 vs 9 alerts in 30 days). CLYM has the smaller float (57.5M vs 342.4M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between CLYM and EVO?
- The differences that matter: they are not in the same business - CLYM is pharmaceutical preparations and EVO is pharmaceutical preparations; they are similar in size ($546M vs $519M); they trade at very different share prices ($9.31 vs $1.44); CLYM sits at 46% of its 52-week range against 4% for EVO; only EVO pays a dividend; our scanner flagged CLYM 119 times in the last 30 days against 9 for EVO. Everything above is measured from the latest completed session and SEC filings.
- Which of CLYM and EVO is more active right now?
- Right now CLYM is at about 0.7x its normal volume and EVO is at about 0.4x, so CLYM is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is CLYM or EVO in the stronger trend?
- CLYM is below its 50-day average of $11.12 and below its 200-day average of $10.76; EVO is below its 50-day average of $1.57 and below its 200-day average of $2.38. They split the head-to-head evenly, 2 measures each (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading CLYM or EVO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.